BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Up 24.4% in March

BiomX Inc. (NYSEAMERICAN:PHGE) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 31,600 shares, a growth of 24.4% from the February 28th total of 25,400 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 87,400 shares, the days-to-cover ratio is presently 0.4 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright boosted their target price on shares of BiomX from $2.00 to $21.00 and gave the company a “buy” rating in a research report on Tuesday.

BiomX Trading Up 27.6 %

Shares of PHGE opened at $0.63 on Thursday. The stock has a market capitalization of $11.44 million, a PE ratio of -0.20 and a beta of 1.27. BiomX has a 52 week low of $0.48 and a 52 week high of $4.99.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).